Honors & News
August 4, 2014
Dr. Ankur Chandra, Associate Professor of Surgery and Biomedical Engineering, Department of Vascular Surgery has been invited to give a talk, entitled Patient-specific modeling of abdominal aortic aneurysms for the study of rupture risk, device testing and surgical planning.
Dr. Chandra is one of the founding members of the Center for Medical Technology and Innovation. He is currently a Certified Registered Physician in Vascular Interpretation. Dr. Chandra's interest in device design and engineering began during his undergraduate degree in BME at Case Western. His focus is to generate a new paradigm of device development in an era of increasing health care cost constraints and limited commercial resources. He hopes that these efforts will directly improve patient care through increased efficiency of clinician-engineer communications, more targeted and effective devices, and shifting device R&D from profit-based to need-based development.
March 18, 2014
Ankur Chandra, associate professor of surgery and biomedical engineering at the University of Rochester, program director of the university's vascular surgery clinical residency program, and a practicing vascular surgeon will present a
Case study: Highly Accurate Prototyping for Medical 3-D Printingat BIOMEDevice Boston, Wednesday, March 26 at 2:40 p.m.
Also a member of the Center for Medical Technology and Innovation (CMTI), Chandra's Cardiovascular Engineering Lab (CVEL) involves a cross-disciplinary, multi-institutional team working towards solving cardiovascular problems using engineering principles. The overall theme of this lab is solving little problems, using the expertise of staff and students from various backgrounds, in order to solve the bigger problems in this field. The cardiovascular system is governed by forces prevalent in engineering, and the team of clinicians and engineers work together on problems faced in the cardiovascular field which can be solved through the application of engineering.
To read more about his case study see the full article here.
February 15, 2014
The School of Medicine & Dentistry is collaborating with the Hajim School of Engineering and Applied Sciences to open the Center for Medical Technology Innovation (CMTI). The new center is forging connections between bioengineering students, health care professionals, and the medical technology industry. The goal is to identify problems and develop solutions.
Associate Professor Ankur Chandra, M.D., RPVI, is a problem solver. When he needed an inexpensive way to generate three-dimensional models for teaching, he and students in his vascular bioengineering lab built their own 3D printer. Instead of using ink, the device draws in a polymer cord and then spits it out again in very thin layers. The layers accumulate to form solid objects. The
homemadeprinter cost thousands less than commercial printers and it makes its own replacement parts. (They're biodegradable, of course.)
To read more about the clinical director of the new Center for Medical Technology Innovation (CMTI) see the full article here.
May 16, 2013
The URMC Cardiovascular Engineering Lab (CVEL) has been awarded the 2013 CTSI/UNYTE pilot Collaborative research grant. The project, entitled, Regional Ultrasound Wall Strain Measurements to Predict Risk of Abdominal Aortic Aneurysm (AAA) rupture, is led by PI's Ankur Chandra, M.D., RPVI, Karl Schwarz, M.D., Steven Day, Ph.D., and Dan Phillips, Ph.D.
UNYTE offers a pilot funding program open to investigators at research institutions across the Upstate region. The objective of the program is to catalyze the formation of multi-institutional, cross-disciplinary research teams that are focused on a critical issue in clinical or translational research. To receive funding, projects must involve collaboration from at least two UNYTE member institutions. Applicants are strongly encouraged to develop an innovative, team-based approach that reflects the research strengths of the participating institutions, as well as of the investigators themselves.
May 16, 2013
Abdominal aortic aneurysms are one of the top ten causes of death in men over the age of 55, and upstate New York has higher rates of this condition than the rest of the country. Researchers are now working on patient-specific diagnosis and treatment, as the Innovation Trail's Kate O'Connell reports.
Dr. Ankur Chandra, a lead investigator at the University of Rochester's Cardio-Vascular Engineering Lab (CVEL), says the prevalence of aortic aneurysms and ruptures in upstate New York points to a need for increased screening.
One thing about the Western New York and upstate region that's critically important is that the prevalence, meaning the number of patients in this region with aortic aneurysms is unusually high when compared with the rest of the country,Chandra says.
October 10, 2012
The University of Rochester is combining its medical, engineering, and entrepreneurial expertise to create the Center for Medical Technology Innovation (CMTI). A collaboration of the Hajim School of Engineering and Applied Sciences and the School of Medicine and Dentistry, CMTI will also make use of the University's Center for Entrepreneurship as it coordinates activities to develop technological solutions to clinical problems.
Ankur Chandra, M.D., the medical director of CMTI, said a recent development at the University of Rochester Medical Center validates the importance of the center's approach. Since multiple medical conditions such as aortic aneurysms can now be addressed by inserting devices through blood vessels - rather than by open surgery - larger catheters are needed to place through the femoral artery in the thigh, the point where the devices are inserted.
One of our students, Rachel Rakvica, noticed that the larger openings allowed for newer techniques to close the artery - a novel approach that did not require incisions,said Chandra.
We've obtained a provisional patent, with the hope of further developing the technology.
Amy Lerner, the academic director of CMTI, has had a great deal of experience guiding students in the medical device development process. An associate professor of biomedical engineering, Lerner directs the senior design course, a year-long program in which teams of students partner with clinicians, companies, and other institutions to solve real-world engineering problems.
The new center will be critical in helping take student and faculty design solutions to the next step,said Lerner.
We'll work closely with industry to address design challenges, which will also help prepare our students for careers in healthcare.
The executive director of CMTI will be Greg Gdowski, who earned a Ph.D. in biomedical engineering at Boston University and worked as a research fellow at Blue Highway, an engineering services company in Syracuse. Gdowski believes the new center will increase the national visibility and stature of the University of Rochester and its biomedical engineering program. He added,
It will also help foster growth and collaboration between faculty at the Hajim School and those at the Medical Center.
September 7, 2012
The CTSI supports medical students interested in a year-out experience of mentored clinical and translational research. Most students will enter through the Academic Research Track (ART), which is the foundation of the CTSI program. Doran Mix, a CTSI TL1 Predoctoral Program trainee, and his team completed a number of multidisciplinary projects that apply biomedical engineering concepts to solve problems in cardiovascular medicine. Mix says his experience with the CTSI has inspired him to continue to do research for the remainder of his career. To learn more about Doran Mix and his research visit his CTSI information page and the Cardiovascular Engineering Lab (CVEL).
- A model to demonstrate that endotension is a nonvisualized type I endoleak.J Vasc Surg. (2015 Jul 24).
- Pulse Wave Velocity Prediction and Compliance Assessment in Elastic Arterial Segments.Cardiovasc Eng Technol. 6, 49-58. (2015 Mar 01).
- Predictors of mortality in patients hospitalized for congestive heart failure with left ventricular ejection fraction ≥ 40.Cardiol J. 22, 382-90. (2015 Jan 01).